CNABusiness
Singapore startups tap China to speed new treatments
Singapore biomedical startups are expanding into China to speed the development of treatments for cancer, diabetes and other diseases. They are seeking access to large patient populations, hospital networks and manufacturing, while adapting to changing regulatory rules.
This card is an AI-assisted summary of reporting published by CNA. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.